News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Francesco Massari: Another Important Experience by ARON Project on First-Line Treatment Options for mRCC patients
Francesco Massari/X
May 30, 2025, 13:07

Francesco Massari: Another Important Experience by ARON Project on First-Line Treatment Options for mRCC patients

Francesco Massari, Medical Oncologist focused on Genitourinary Cancer at The University Hospital of Bologna IRCCS, shared a post on X:

“Pembro/Axi vs. Nivo/Cabo
as first-line therapy in mRCC patients.
Out now another important experience by ARON Project.”

ARON Project

Title: Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line therapy in patients with metastatic renal cell carcinoma: a retrospective real-world comparison (ARON-1)

Authors: Matteo Santoni, Giandomenico Roviello, Enrique Grande, Ugo De Giorgi, Ondrej Fiala, Emmanuel Seront, Javier Molina-Cerrillo, Renate Pichler, Zin W Myint, Jakub Kucharz, Ravindran Kanesvaran, Thomas Büttner, Martin Pichler, Umberto Basso, Jindrich Kopecky, Maria T Bourlon, Linda Cerbone, Tomas Buchler, Alvaro Pinto, Alfonso Gómez de Liaño, Caterina Gianni, Anca Zgura, Pasquale Rescigno, Jawaher Ansari, Orazio Caffo, Zsófia Küronya, Maria Giuseppa Vitale, Dipen Bhuva, Martina Catalano, Nuno Vau, Ray Manneh Kopp, Sebastiano Buti, Aristotelis Bamias, Camillo Porta, Kaisa Sunela, Francesco Massari

Read Full Article.

Francesco Massari: Another Important Experience by ARON Project on First-Line Treatment Options for mRCC patients

More posts featuring Renal Cell Carcinoma on OncoDaily.

Alfonso Gómez de Liaño Alvaro Pinto Anca Zgura Aristotelis Bamias ARON project Camillo Porta cancer Caterina Gianni Dipen Bhuva Emmanuel Seront Enrique Grande Francesco Massari Giandomenico Roviello Jakub Kucharz Javier Molina Cerrillo Jawaher Ansari Jindrich Kopecky Kaisa Sunela Linda Cerbone Maria Giuseppa Vitale Maria T Bourlon Martin Pichler Martina Catalano Matteo Santoni Nuno Vau OncoDaily Oncology Ondřej Fiala Orazio Caffo Pasquale Rescigno Ravindran Kanesvaran Ray Manneh Kopp Renate Pichler Sebastiano Buti Thomas Büttner Tomas Buchler Ugo de Giorgi Umberto Basso Zin W. Myint Zsófia Küronya
Special Coverage
Science
May 30, 2025, 13:07
Francesco Massari: Another Important Experience by ARON Project on First-Line Treatment Options for mRCC patients
Stories
May 30, 2025, 12:53
Digestive Cancers Europe shared Oesophageal Cancer Patient Story On WDHD 2025
Science
May 30, 2025, 12:46
Myeloma Paper of the Day, May 30th, suggested by Robert Orlowski
Opinion
May 30, 2025, 12:29
Supriya Peshin: Don't Miss the Powerful Session with Rami Manochakian at ASCO 2025
Blog
May 30, 2025, 11:52
Celia Diez de los Rios: Maria Teresa Lluch on Mental Health in Oncology at 10th National Congress of Spanish Oncology Nurses
Oncologist Near Me
May 30, 2025, 11:42
Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Blog
May 30, 2025, 10:47
Richard Goldberg: Agenus Anticipates Interacting with FDA with New Data Coming at ESMO-GI 2025
Drugs
May 30, 2025, 09:55
ASCO25 Update: Tres Uramigas Highlighted Data on ADC and PD-1 Combinations in Bladder Cancer
Blog
May 30, 2025, 09:10
Dean Crowe: You Never Forget The War You Waged With Childhood Cancer
Blog
May 30, 2025, 08:55
Elizabeth F. Franklin and Tom Snow on Sanofi's Commitment to Patient-Centric Innovation in Oncology
Blog
May 30, 2025, 07:57
Stephen V Liu: Congratulations to The Newly Elected IASLC Board Members
Blog
May 30, 2025, 07:49
Alexandru Eniu: Addressing Financial Toxicity in Breast Cancer Care Session at ASCO25